Akorn, Inc. Announces FDA Approval of Ciprofloxacin HCl Ophthalmic Solution USP, 0.3%

Dec 12, 2008 - Akorn, Inc. today announced that the U.S. Food and Drug Administration has granted approval for Akorn's Abbreviated New Drug Application for Ciprofloxacin HCl Ophthalmic Solution USP, 0.3%.

The details can be read here.